Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05887557 · ClinicalTrials.gov registry record · NA

Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation

A NA study of HIV, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
5
Study locations

NCT05887557 is a NA study of HIV that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 400 participants, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target. The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05887557, a NA study of HIV, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to evaluate the implementation and effectiveness of a flexible, multidisciplinary, integrated drop-in/mobile HIV care approach for people living with HIV (PLH) who are not well engaged in current care systems (i.e. scheduled HIV primary care visits). The hybrid type 2 implementation-effectiveness study involves a set of implementation strategies to support implementation of the integrated drop-in/mobile HIV care approach (i.e. the evidence-informed clinical intervention) at four diverse sites in San Francisco and Alameda counties in California. Sites include an academic clinic located at a public hospital (Ward 86) and a needle exchange site (San Francisco AIDS Foundation Syringe Access Site) in San Francisco and two Federally Qualified Health Centers serving diverse patient populations in Alameda County (Trust and La Clínica). The evidence-informed clinical intervention consists of four key components: 1) active referral to care sites; 2) drop-in, multidisciplinary HIV primary care; 3) mobile HIV care; and 4) staged escalation/de-escalation of care level as needed. The study will use RE-AIM to guide evaluation, with coprimary outcomes of Reach and HIV viral suppression, and mixed methods to assess intervention Adoption, Implementation, and Maintenance. The study draws on the CFIR framework to assess site-specific implementation determinants before and after the study period. The study will undertake micro-costing using a uniform cost data collection protocol to quantify the resources needed to carry out intervention activities.

Conditions Studied

Interventions

  • OTHER Active Referral
  • OTHER Drop-In Multidisciplinary HIV Care
  • OTHER Mobile HIV Care
  • OTHER Staged Care
  • OTHER Identify and prepare champions at referral sites

Study Locations (5)

California

  • La Clinica de la Raza, Inc - Oakland
  • Lifelong Medical Care - Oakland
  • San Francisco AIDS Foundation - San Francisco
  • San Francisco Department of Public Health Maria X Martinez Clinic - San Francisco
  • Zuckerberg San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-05-16
Est. Completion 2027-03-31
Phase NA

What the Registry Record Tells You About NCT05887557

The ClinicalTrials.gov registry entry for NCT05887557 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 5 interventions - of which Active Referral is the first listed.

NCT05887557 reports 5 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05887557 about?

NCT05887557 is a clinical study titled "Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation". The purpose of this study is to evaluate the implementation and effectiveness of a flexible, multidisciplinary, integrated drop-in/mobile HIV care approach for people living with HIV (PLH) who are not well engaged in current care systems (i.e. scheduled HIV primary care visits). The hybrid type 2 im...

What is the current status of trial NCT05887557?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-05-16. Estimated completion is 2027-03-31.

What conditions does trial NCT05887557 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT05887557?

The interventions under investigation include: Active Referral (OTHER), Drop-In Multidisciplinary HIV Care (OTHER), Mobile HIV Care (OTHER), Staged Care (OTHER), Identify and prepare champions at referral sites (OTHER).

Who is sponsoring clinical trial NCT05887557?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05887557 being conducted?

This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.